Health status and access to health services among the urban homeless.
M. Robertson, M. Cousineau
semanticscholar +1 more source
ABSTRACT Objective We aim to comprehensively analyze how regional tumor and edema characteristics are associated with clinical presentations and survival outcomes in a large cohort of glioblastoma patients. Methods Patients with IDH‐wildtype glioblastoma who received brain MRI from 2010 to 2023 were included.
Daniel J. Zhou +16 more
wiley +1 more source
Barriers facilitators and needs of female sex workers in Arak to access sexual health services a qualitative study. [PDF]
Navidi I +3 more
europepmc +1 more source
Factors Influencing Access to Health Services among Chronically Ill Older Adults with Physical Disabilities in the Era of the COVID-19 Outbreak. [PDF]
Nanthamongkolchai S +3 more
europepmc +1 more source
Regular source of ambulatory care and access to health services.
R. A. Hayward +3 more
semanticscholar +1 more source
Long‐Term Efficacy of Immunotherapy in Autoimmune Autonomic Ganglionopathy—A 10‐Year Follow Up Study
ABSTRACT Objective Autoimmune autonomic ganglionopathy (AAG) is a rare but potentially treatable cause of severe autonomic failure. Evidence guiding long‐term immunotherapy, treatment sequencing, and residual autonomic impairment is limited. We evaluated long‐term treatment response, residual autonomic dysfunction, and relapse patterns in patients with
Giacomo Chiaro +6 more
wiley +1 more source
Can Insurance Guarantee Universal Access to Health Services?
Can Insurance Guarantee Universal Access to Health Services?
Asa Cristina Laurell
doaj
Access to health services by women subjected to violence: findings from administrative healthcare data from the metropolitan area of northern Italy. [PDF]
Gabellini E +6 more
europepmc +1 more source
C. Borrell +6 more
semanticscholar +1 more source
Efficacy of Inebilizumab in N‐MOmentum Trial Participants With or Without Prior Immunosuppressants
ABSTRACT This post hoc analysis examined the impact of prior immunosuppressants on the long‐term efficacy and safety of inebilizumab, a cluster of differentiation 19+ B‐cell–depleting monoclonal antibody, in participants with aquaporin‐4–seropositive neuromyelitis optica spectrum disorder from the N‐MOmentum trial (NTC02200770).
Bruce A. C. Cree +9 more
wiley +1 more source

